- Title
- Open-label phase II study evaluating the efficacy of concurrent administration of radium Ra 223 dichloride and abiraterone acetate in men with castration-resistant prostate cancer patients with symptomatic bone metastases
- Creators
- Luke T. Nordquist - Urology Cancer Center and GU Research NetworkNeal D. Shore - Carolina Urologic Research Center
- Publication Details
- Journal of clinical oncology, Vol.34(15_suppl), pp.e16546-e16546
- Identifiers
- 991006262306602656
- Academic Unit
- Radiology
- Language
- English
- Resource Type
- Journal article
Journal article
Open-label phase II study evaluating the efficacy of concurrent administration of radium Ra 223 dichloride and abiraterone acetate in men with castration-resistant prostate cancer patients with symptomatic bone metastases
Journal of clinical oncology, Vol.34(15_suppl), pp.e16546-e16546
05/20/2016
Metrics
1 Record Views